New, potent, small molecule agonists of tyrosine kinase receptors attenuate dry eye disease.

Treatment with C1 significantly increased conjunctival GC density, while treatment with pan increased goblet cell density but did not reach statistical significance ( Figure 1D ).

also in 111,027 other papers